首页> 外文OA文献 >>Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer

【2h】

>Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer

机译：>血清CircsetdB1是一种有前途的生物标志物，用于预测对铂 - 紫杉烷组合的化疗和复发高档浆液癌的反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wei Wang; Jinshu Wang; Xinzhong Zhang; Gang Liu;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer [J] . Wei Wang, Jinshu Wang, Xinzhong Zhang, OncoTargets and therapy . 2019,第3期

机译：血清circSETDB1是有前途的生物标志物，可预测铂-紫杉烷类联合化疗对复发性浆液性卵巢癌的反应
2. Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer [J] . Vallius Tuulia, Hynninen Johanna, Auranen Annika, Tumour biology : . 2014,第12期

机译：血清HE4和CA125可作为晚期晚期浆液性卵巢癌新辅助化疗期间反应和预后的指标
3. High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers [J] . M Miyamoto, M Takano, K Iwaya, British Journal of Cancer . 2015,第4期

机译：高温需要的蛋白A2作为高级别浆液性卵巢癌患者对化疗和预后的预测指标
4. Evaluation of chemotherapy response in ovarian cancer treatment using quantitative CT image biomarkers: A preliminary study [C] . Yuchen Qiu, Maxine Tan, Scott McMeekin, Conference on computer-aided diagnosis . 2015

机译：使用定量CT图像生物标记物评估卵巢癌治疗中的化疗反应：初步研究
5. Evaluation of Autoantibodies to Paraneoplastic Antigens as Early Detection Biomarkers for High-Grade Serous Ovarian Cancer [D] . Hurley, Laura Catherine. 2020

机译：对偏生剂抗原的自身抗体评价为早期检测生物标志物，高级浆液癌
6. Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer [O] . Wei Wang, Jinshu Wang, Xinzhong Zhang, 2019

机译：血清circSETDB1是有前途的生物标志物可预测铂-紫杉烷类联合化疗对复发性浆液性卵巢癌的反应
7. 3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer. [O] . Jeyshka M. Reyes-Gonzalez, Sharee Umpierre, Pablo E. Vivas-Mejia 2019

机译：3468 Puerto Rican西班牙裔患者的铂基化疗反应预测生物标志物，具有高级浆膜卵巢癌。

>Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer

著录项

引文网络

相似文献

相关主题

期刊订阅